Jeffrey Smith
Faculty Member
Last active: 3/14/2018


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. Chung CP, Solus JF, Oeser A, Li C, Raggi P, Smith JR, Stein CM (2015) Int J Mol Sci 16(2): 3885-94
    › Primary publication · 25679449 (PubMed) · PMC4346932 (PubMed Central)
  2. Genetics of serum concentration of IL-6 and TNF╬▒ in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis. Solus JF, Chung CP, Oeser A, Li C, Rho YH, Bradley KM, Kawai VK, Smith JR, Stein CM (2015) Clin Rheumatol 34(8): 1375-82
    › Primary publication · 25652333 (PubMed) · PMC4526456 (PubMed Central)
  3. Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis. Weng PH, Huang YL, Page JH, Chen JH, Xu J, Koutros S, Berndt S, Chanock S, Yeager M, Witte JS, Eeles RA, Easton DF, Neal DE, Donovan J, Hamdy FC, Muir KR, Giles G, Severi G, Smith JR, Balistreri CR, Shui IM, Chen YC (2014) PLoS One 9(10): e110569
    › Primary publication · 25360682 (PubMed) · PMC4215920 (PubMed Central)
  4. Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus. Chung CP, Solus JF, Oeser A, Li C, Raggi P, Smith JR, Stein CM (2014) Lupus 23(9): 876-80
    › Primary publication · 24699314 (PubMed) · PMC4185017 (PubMed Central)
  5. An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility. Breyer JP, Dorset DC, Clark TA, Bradley KM, Wahlfors TA, McReynolds KM, Maynard WH, Chang SS, Cookson MS, Smith JA, Schleutker J, Dupont WD, Smith JR (2014) Am J Hum Genet 94(3): 395-404
    › Primary publication · 24581739 (PubMed) · PMC3951923 (PubMed Central)
  6. Loss of col8a1a function during zebrafish embryogenesis results in congenital vertebral malformations. Gray RS, Wilm TP, Smith J, Bagnat M, Dale RM, Topczewski J, Johnson SL, Solnica-Krezel L (2014) Dev Biol 386(1): 72-85
    › Primary publication · 24333517 (PubMed) · PMC3938106 (PubMed Central)
  7. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D Levels among African Americans. Signorello LB, Shi J, Cai Q, Zheng W, Williams SM, Long J, Cohen SS, Li G, Hollis BW, Smith JR, Blot WJ (2011) PLoS One 6(12): e28623
    › Primary publication · 22205958 (PubMed) · PMC3244405 (PubMed Central)
  8. HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene-environment interactions and candidate genes. Edwards TL, Velez Edwards DR, Villegas R, Cohen SS, Buchowski MS, Fowke JH, Schlundt D, Long J, Long JR, Cai Q, Zheng W, Shu XO, Hargreaves MK, Smith J, Jeffrey S, Williams SM, Signorello LB, Blot WJ, Matthews CE (2012) Am J Epidemiol 175(1): 11-21
    › Primary publication · 22106445 (PubMed) · PMC3244609 (PubMed Central)
  9. An SNP-Based Linkage Map for Zebrafish Reveals Sex Determination Loci. Bradley KM, Breyer JP, Melville DB, Broman KW, Knapik EW, Smith JR (2011) G3 (Bethesda) 1(1): 3-9
    › Primary publication · 21949597 (PubMed) · PMC3178105 (PubMed Central)
  10. The feelgood mutation in zebrafish dysregulates COPII-dependent secretion of select extracellular matrix proteins in skeletal morphogenesis. Melville DB, Montero-Balaguer M, Levic DS, Bradley K, Smith JR, Hatzopoulos AK, Knapik EW (2011) Dis Model Mech 4(6): 763-76
    › Primary publication · 21729877 (PubMed) · PMC3209646 (PubMed Central)
  11. Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction. Crooke PS, Justenhoven C, Brauch H, GENICA Consortium, Dawling S, Roodi N, Higginbotham KS, Plummer WD, Schuyler PA, Sanders ME, Page DL, Smith JR, Dupont WD, Parl FF (2011) Cancer Epidemiol Biomarkers Prev 20(7): 1502-15
    › Primary publication · 21610218 (PubMed) · PMC3472969 (PubMed Central)
  12. A multistage association study identifies a breast cancer genetic locus at NCOA7. Higginbotham KS, Breyer JP, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Sanders ME, Page DL, Parl FF, Egan KM, Dupont WD, Smith JR (2011) Cancer Res 71(11): 3881-8
    › Primary publication · 21610108 (PubMed) · PMC3137260 (PubMed Central)
  13. ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and BMI in black and white women. Cohen SS, Gammon MD, North KE, Millikan RC, Lange EM, Williams SM, Zheng W, Cai Q, Long J, Smith JR, Signorello LB, Blot WJ, Matthews CE (2011) Obesity (Silver Spring) 19(10): 2053-62
    › Primary publication · 21273992 (PubMed) · PMC3474141 (PubMed Central)
  14. Blood vitamin d levels in relation to genetic estimation of African ancestry. Signorello LB, Williams SM, Zheng W, Smith JR, Long J, Cai Q, Hargreaves MK, Hollis BW, Blot WJ (2010) Cancer Epidemiol Biomarkers Prev 19(9): 2325-31
    › Primary publication · 20647395 (PubMed) · PMC2938736 (PubMed Central)
  15. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer. Love HD, Booton SE, Boone BE, Breyer JP, Koyama T, Revelo MP, Shappell SB, Smith JR, Hayward SW (2009) PLoS One 4(12): e8384
    › Primary publication · 20027305 (PubMed) · PMC2793011 (PubMed Central)
  16. Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk. Dupont WD, Breyer JP, Bradley KM, Schuyler PA, Plummer WD, Sanders ME, Page DL, Smith JR (2010) Cancer 116(1): 8-19
    › Primary publication · 19890961 (PubMed) · PMC2807897 (PubMed Central)
  17. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, Benediktsdottir KR, Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, Stacey SN, Sigurdsson A, Wahlfors T, Tammela T, Breyer JP, McReynolds KM, Bradley KM, Saez B, Godino J, Navarrete S, Fuertes F, Murillo L, Polo E, Aben KK, van Oort IM, Suarez BK, Helfand BT, Kan D, Zanon C, Frigge ML, Kristjansson K, Gulcher JR, Einarsson GV, Jonsson E, Catalona WJ, Mayordomo JI, Kiemeney LA, Smith JR, Schleutker J, Barkardottir RB, Kong A, Thorsteinsdottir U, Rafnar T, Stefansson K (2009) Nat Genet 41(10): 1122-6
    › Primary publication · 19767754 (PubMed) · PMC3562712 (PubMed Central)
  18. Heritable variation of ERBB2 and breast cancer risk. Breyer JP, Sanders ME, Airey DC, Cai Q, Yaspan BL, Schuyler PA, Dai Q, Boulos F, Olivares MG, Bradley KM, Gao YT, Page DL, Dupont WD, Zheng W, Smith JR (2009) Cancer Epidemiol Biomarkers Prev 18(4): 1252-8
    › Primary publication · 19336545 (PubMed) · PMC2730036 (PubMed Central)
  19. Association of mitochondrial DNA displacement loop (CA)n dinucleotide repeat polymorphism with breast cancer risk and survival among Chinese women. Ye C, Gao YT, Wen W, Breyer JP, Shu XO, Smith JR, Zheng W, Cai Q (2008) Cancer Epidemiol Biomarkers Prev 17(8): 2117-22
    › Primary publication · 18708405 (PubMed) · PMC2643086 (PubMed Central)
  20. Genetic differences in human circadian clock genes among worldwide populations. Ciarleglio CM, Ryckman KK, Servick SV, Hida A, Robbins S, Wells N, Hicks J, Larson SA, Wiedermann JP, Carver K, Hamilton N, Kidd KK, Kidd JR, Smith JR, Friedlaender J, McMahon DG, Williams SM, Summar ML, Johnson CH (2008) J Biol Rhythms 23(4): 330-40
    › Primary publication · 18663240 (PubMed) · PMC2579796 (PubMed Central)
  21. A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer. Yaspan BL, McReynolds KM, Elmore JB, Breyer JP, Bradley KM, Smith JR (2008) Hum Genet 123(4): 379-86
    › Primary publication · 18350320 (PubMed) · PMC2811403 (PubMed Central)
  22. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study. Cai Q, Kataoka N, Li C, Wen W, Smith JR, Gao YT, Shu XO, Zheng W (2008) Cancer Epidemiol Biomarkers Prev 17(1): 27-32
    › Primary publication · 18199708 (PubMed) · PMC2633134 (PubMed Central)
  23. Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk. Yaspan BL, Breyer JP, Cai Q, Dai Q, Elmore JB, Amundson I, Bradley KM, Shu XO, Gao YT, Dupont WD, Zheng W, Smith JR (2007) Cancer Res 67(12): 5673-82
    › Primary publication · 17575134 (PubMed) · PMC2805128 (PubMed Central)
  24. A major zebrafish polymorphism resource for genetic mapping. Bradley KM, Elmore JB, Breyer JP, Yaspan BL, Jessen JR, Knapik EW, Smith JR (2007) Genome Biol 8(4): R55
    › Primary publication · 17428331 (PubMed) · PMC1896001 (PubMed Central)
  25. Genome-wide linkage identifies novel modifier loci of aganglionosis in the Sox10Dom model of Hirschsprung disease. Owens SE, Broman KW, Wiltshire T, Elmore JB, Bradley KM, Smith JR, Southard-Smith EM (2005) Hum Mol Genet 14(11): 1549-58
    › Primary publication · 15843399 (PubMed)
  26. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival. Boyapati SM, Shu XO, Ruan ZX, Cai Q, Smith JR, Wen W, Gao YT, Zheng W (2005) Clin Cancer Res 11(3): 1093-8
    › Primary publication · 15709176 (PubMed)
  27. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Wen W, Gao YT, Shu XO, Yu H, Cai Q, Smith JR, Zheng W (2005) Int J Cancer 113(2): 307-11
    › Primary publication · 15386404 (PubMed)
  28. Interactions between Sox10 and EdnrB modulate penetrance and severity of aganglionosis in the Sox10Dom mouse model of Hirschsprung disease. Cantrell VA, Owens SE, Chandler RL, Airey DC, Bradley KM, Smith JR, Southard-Smith EM (2004) Hum Mol Genet 13(19): 2289-301
    › Primary publication · 15294878 (PubMed)
  29. Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Zheng W, Gao YT, Shu XO, Wen W, Cai Q, Dai Q, Smith JR (2004) Cancer Epidemiol Biomarkers Prev 13(5): 709-14
    › Primary publication · 15159300 (PubMed)
  30. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene. Cai Q, Gao YT, Wen W, Shu XO, Jin F, Smith JR, Zheng W (2003) Cancer Res 63(18): 5727-30
    › Primary publication · 14522892 (PubMed)